alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,301–6,325 of 7,816 matching trials · page 253 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Safety and Tolerability of PQ912 in Subjects With Early Alzheimer's Disease
NCT02389413
PQ912 oral; Placebo
Runs in: Belgium; Finland; France; Germany; Netherlands; Spain; Sweden · 23 sites 		PHASE2
other		 COMPLETED 120 Vivoryon Therapeutics N.V.
INDUSTRY		 2017-06-01
Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
NCT01018927
Administering three additional MRI images
Runs in: United States · 1 site 		NA
other		 TERMINATED 44 University of Arkansas
OTHER		 2017-05-31
Evaluation of "My Tools 4 Care" for Family Caregivers of Persons With Dementia
NCT02428387
My Tools 4 Care
Runs in: Canada · 2 sites 		NA
other		 COMPLETED 199 University of Alberta
OTHER		 2017-05-31
Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population
NCT02967406
4 x 4 lifestyle modification
Runs in: Thailand · 1 site 		NA
other		 ACTIVE_NOT_RECRUITING 3,600 Sanpasitthiprasong Hospital
OTHER_GOV		 2017-05-31
A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy
NCT01677754
RO4602522; Placebo; Donepezil; Memantine; Rivastigmine; Galantamine
Runs in: Australia; Canada; Czechia; France; Germany; Italy; Polan... · 142 sites 		PHASE2
symptomatic-cholinergic		 COMPLETED 542 Hoffmann-La Roche
INDUSTRY		 2017-05-30
Memantine Treatment in Alzheimer's Disease Patients
NCT03168997
Memantine Hydrochloride 		PHASE4
symptomatic-cholinergic		 UNKNOWN 222 Wei Cuibai
OTHER		 2017-05-30
Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
NCT00381238
rosiglitazone
Runs in: Canada; United States · 7 sites 		PHASE2
other		 COMPLETED 33 GlaxoSmithKline
INDUSTRY		 2017-05-23
Zolpidem CR and Hospitalized Patients With Dementia
NCT00814502
Zolpidem CR; Placebo
Runs in: United States · 1 site 		NA
other		 COMPLETED 20 Massachusetts General Hospital
OTHER		 2017-05-22
Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
NCT00428090
Rosiglitazone
Runs in: Austria; Bulgaria; Chile; China; Croatia; Estonia; German... · 138 sites 		PHASE3
other		 COMPLETED 862 GlaxoSmithKline
INDUSTRY		 2017-05-19
SHARED DECISION MAKING IN LONG-TERM CARE FACILITIES
NCT02118701
Shared Decision-Making educational training 		NA
other		 COMPLETED 40 Radboud University Medical Center
OTHER		 2017-05-19
Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease
NCT02305836
acupuncture; donepezil
Runs in: China · 1 site 		PHASE2
symptomatic-cholinergic		 UNKNOWN 334 Guang'anmen Hospital of China Academy of Chinese Medical Sciences
OTHER		 2017-05-16
Research on the Early and Prognosis Diagnosis of Vascular Dementia
NCT03152630
Runs in: Taiwan · 1 site 		NA
other		 RECRUITING 600 National Taiwan University Hospital
OTHER		 2017-05-15
A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease
NCT03151382
Tandospirone Citrate; Donepezil Hydrochloride 		PHASE4
symptomatic-cholinergic		 UNKNOWN 30 Zhejiang Provincial People's Hospital
OTHER		 2017-05-12
Neuro Imaging and Multimodal Alzheimer's Disease
NCT02839187
Neuroimaging
Runs in: France · 1 site 		NA
other		 COMPLETED 59 University Hospital, Toulouse
OTHER		 2017-05-11
Cognitive Changes After Major Joint Replacement
NCT02964221
Cognitive Testing 		NA
other		 COMPLETED 90 Dr. Stephen Choi
OTHER		 2017-05-10
Bupropion for the Treatment of Apathy in Alzheimer's Dementia
NCT01047254
Elontril; placebo
Runs in: Germany · 1 site 		PHASE3
other		 COMPLETED 110 University Hospital, Bonn
OTHER		 2017-05-09
Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects
NCT01702480
GSK2981710; Placebo
Runs in: United Kingdom · 1 site 		PHASE1
other		 COMPLETED 116 GlaxoSmithKline
INDUSTRY		 2017-05-09
Serotonergic Function and Behavioural and Psychological Symptoms of Frontotemporal Dementia
NCT00376051
Citalopram
Runs in: Canada · 2 sites 		PHASE4
other		 COMPLETED 22 Sunnybrook Health Sciences Centre
OTHER		 2017-05-05
The Impact of Supplementation With Multi-vitamins/Minerals, With and Without Fatty Acids, on Impulsivity and Aggression
NCT01558193
Placebo; Multi-vitamin/mineral; Docosahexaenoic acid; DHA plus vita...
Runs in: United Kingdom · 1 site 		NA
other		 COMPLETED 202 Swansea University
OTHER		 2017-05-05
Characterization of the Profile of Dysarthria in Huntington's Disease, Using the Clinical Evaluation Battery of Dysarthria
NCT03142217
Study of dysarthria in patients with Huntington's disease 		NA
other		 WITHDRAWN 0 Centre Hospitalier Universitaire, Amiens
OTHER		 2017-05-05
Computational Tools for Early Diagnosis of Memory Disorders
NCT02050464
Runs in: Finland · 3 sites 		NA
other		 COMPLETED 126 University of Eastern Finland
OTHER		 2017-05-04
Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial
NCT02295462
Person-centered Care; Optimised Treatment
Runs in: Germany · 3 sites 		NA
other		 COMPLETED 1,158 Martin-Luther-Universität Halle-Wittenberg
OTHER		 2017-05-03
Implementation of a Multicomponent Intervention to Prevent Physical Restraints in Nursing Home Residents (IMPRINT)
NCT02341898
Educational programme for all nurses; Training and structured suppo...
Runs in: Germany · 4 sites 		NA
other		 COMPLETED 10,800 University of Luebeck
OTHER		 2017-05-03
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
NCT00329706
FDG-PET brain scan
Runs in: United States · 9 sites 		NA
other		 COMPLETED 710 University of California, Los Angeles
OTHER		 2017-05-02
Down Syndrome Biomarker Initiative (DSBI)
NCT02141971
Runs in: United States · 1 site 		NA
other		 COMPLETED 12 Michael Rafii
OTHER		 2017-05-02

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →